In Vivo Delivery Approaches Influence Immune Responses Induced by Chitosan-Dna Vaccination

徐薇,沈燕,张进平,王缨,熊思东

DOI: https://doi.org/10.3969/j.issn.1000-8861.2003.04.002

2003-01-01

Abstract:Objective To characterize the specific immune responses induced by chitosan embedded pcDNA3-VP1 gene vaccine via intramuscular, oral and intranasal routes so as to find an effective immunization approach for this novel chitosan-DNA vaccine.Methods Balb/c mice were immunized with chitosan-pcDNA3-VP1 vaccine containing CVB3 VP1 encoding sequences intramuscularly, orally and intranasally, three times with 50 μg DNA each time, CVB3 specific IgM, IgG and IgA were detected by ELISA to evaluate the humoral immune response induced by chitosan-DNA vaccine and specific lymphoproliferation to VP1 peptide and CTL activity were also examined representing cellular immune responses induced. Finally, mice were challenged with 5LD 50 CVB3 four weeks after the last immunization.Results In terms of CVB3-specific humoral immune responses, intramuscular immunization with chitosan-pcDNA3-VP1 generated high levels of CVB3 specific IgM and IgG but not mucosal IgA; intranasal immunization elicited high levels of both IgG and mucosal IgA while oral immunization induced only low level of mucosal IgA. As to the cellular immune responses induced by chitosan-DNA vaccine, only splenocytes from mice immunized intranasally responsed to VP1 peptide and showed high CTL activity. Cellular immune response induced by oral immunization was a little weaker while those by intramuscular immunization were too low to be detected. 33.3% mice following intranasal immunization with chitosan-pcDNA3-VP1 survived from lethal CVB3 challenge, while the survival rate of oral and intramuscular immunization groups was 16.7% and 0 separately.Conclusion Intranasal delivery of chitosan-pcDNA3-VP1 vaccine could be the most effective administration route to induce stronger immune responses and immunoprotection against CVB3.